| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |